Arch Pharmalabs Ltd. - Research Center
524729 MERVEND Group (Z) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 10 | Mar ' 09 | Mar ' 08 | Mar ' 07 | Mar ' 06 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 1,023.37 | 713.33 | 514.20 | 362.55 | 246.89 |
| Expenses | |||||
| Material consumed | 664.46 | 489.10 | 351.78 | 242.56 | 162.56 |
| Manufacturing expenses | 29.51 | 26.79 | 18.34 | 16.68 | 13.67 |
| Personnel expenses | 49.83 | 36.14 | 21.03 | 15.18 | 10.64 |
| Selling expenses | 10.17 | 7.63 | 7.78 | 4.46 | 3.34 |
| Adminstrative expenses | 41.00 | 35.44 | 19.82 | 14.15 | 9.84 |
| Expenses capitalised | -13.30 | -25.18 | - | - | - |
| Cost of sales | 781.67 | 569.92 | 418.74 | 293.02 | 200.07 |
| Operating profit | 241.70 | 143.41 | 95.46 | 69.53 | 46.83 |
| Other recurring income | 6.45 | 2.07 | 3.47 | 1.56 | 0.53 |
| Adjusted PBDIT | 248.15 | 145.48 | 98.92 | 71.08 | 47.36 |
| Financial expenses | 131.24 | 59.64 | 35.71 | 24.96 | 15.75 |
| Depreciation | 45.87 | 24.01 | 16.06 | 11.93 | 8.26 |
| Other write offs | - | - | 0.37 | 0.37 | 0.37 |
| Adjusted PBT | 71.04 | 61.83 | 46.78 | 33.82 | 22.98 |
| Tax charges | 20.59 | 16.51 | 13.17 | 9.67 | 7.26 |
| Adjusted PAT | 50.45 | 45.32 | 33.61 | 24.15 | 15.72 |
| Non recurring items | 0.43 | -7.26 | -0.16 | 6.01 | 0.18 |
| Other non cash adjustments | - | -1.29 | -0.37 | - | 0.02 |
| Reported net profit | 50.88 | 36.77 | 33.08 | 30.17 | 15.91 |
| Earnigs before appropriation | 164.74 | 122.31 | 98.92 | 67.11 | 37.26 |
| Equity dividend | - | - | - | - | - |
| Preference dividend | - | - | 0.47 | 0.75 | 0.27 |
| Dividend tax | - | - | 0.08 | 0.13 | 0.04 |
| Retained earnings | 164.74 | 122.31 | 98.38 | 66.23 | 36.95 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis